MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 75 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $111,000 | +246.9% | 43,800 | +200.0% | 0.00% | – |
| Q4 2019 | $32,000 | -98.0% | 14,600 | -96.5% | 0.00% | -100.0% |
| Q2 2018 | $1,606,000 | 0.0% | 420,400 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $1,606,000 | -67.8% | 420,400 | -31.3% | 0.00% | -66.7% |
| Q4 2017 | $4,991,000 | +179.9% | 611,677 | +101.4% | 0.01% | +200.0% |
| Q3 2017 | $1,783,000 | – | 303,777 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |